These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 9559305

  • 1. [Fluoxetine: relations between plasma concentration and therapeutic effects in 32 patients with major depression and treated with 20 mg/day].
    Bourdeaux R, Pannetier P, Younos C, Desor D, Lehr PR, Capolaghi B.
    Encephale; 1998; 24(1):57-61. PubMed ID: 9559305
    [Abstract] [Full Text] [Related]

  • 2. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
    Maes M, Westenberg H, Vandoolaeghe E, Demedts P, Wauters A, Neels H, Meltzer HY.
    J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986
    [Abstract] [Full Text] [Related]

  • 3. Fluoxetine in depressed patients on dialysis.
    Blumenfield M, Levy NB, Spinowitz B, Charytan C, Beasley CM, Dubey AK, Solomon RJ, Todd R, Goodman A, Bergstrom RF.
    Int J Psychiatry Med; 1997 Oct; 27(1):71-80. PubMed ID: 9565715
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cortisol level in men with major depressive disorder treated with fluoxetine or imipramine.
    Piwowarska J, Dryll K, Szelenberger W, Pachecka J.
    Acta Pol Pharm; 2008 Oct; 65(1):159-64. PubMed ID: 18536191
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function.
    Levy NB, Blumenfield M, Beasley CM, Dubey AK, Solomon RJ, Todd R, Goodman A, Bergstrom RR.
    Gen Hosp Psychiatry; 1996 Jan; 18(1):8-13. PubMed ID: 8666216
    [Abstract] [Full Text] [Related]

  • 9. Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment.
    Brunswick DJ, Amsterdam JD, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Beasley CM.
    J Affect Disord; 2002 Apr; 68(2-3):243-9. PubMed ID: 12063152
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression.
    Amsterdam JD, Luo L, Shults J.
    J Clin Psychopharmacol; 2013 Jun; 33(3):420-4. PubMed ID: 23609385
    [Abstract] [Full Text] [Related]

  • 12. Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study.
    Heiligenstein JH, Hoog SL, Wagner KD, Findling RL, Galil N, Kaplan S, Busner J, Nilsson ME, Brown EB, Jacobson JG.
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(1-2):207-17. PubMed ID: 16553541
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Disposition of chiral and racemic fluoxetine and norfluoxetine across childbearing.
    Sit D, Perel JM, Luther JF, Wisniewski SR, Helsel JC, Wisner KL.
    J Clin Psychopharmacol; 2010 Aug; 30(4):381-6. PubMed ID: 20631556
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum cortisol concentration in patients with major depression after treatment with fluoxetine.
    Piwowarska J, Chimiak A, Matsumoto H, Dziklińska A, Radziwoń-Zaleska M, Szelenberger W, Pachecka J.
    Psychiatry Res; 2012 Aug 15; 198(3):407-11. PubMed ID: 22429479
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.
    Kim J, Riggs KW, Misri S, Kent N, Oberlander TF, Grunau RE, Fitzgerald C, Rurak DW.
    Br J Clin Pharmacol; 2006 Feb 15; 61(2):155-63. PubMed ID: 16433870
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.